Sorrento Therapeutics Inc (SRNE)

[Andecker]

Well, I wonder who is to blame for not being able to solidify a deal? Mr. Brunswick? Is he not liked by FDA?

RE: Earnings - a couple sources I saw noted they will be released today, Friday, 3/4 (Schwaab for one). Looks like it will be done similar to how some of our government entities handle less than good news. Called a "document dump" - they purposely wait until last minute on Friday - right before weekend starts. Those dumping hope the sheeple won't notice as they prepare for weekend of indulging in the new party favorite - fentanyl - now streaming over our open southern boarder in record amounts or cheap beer like I like to drink, hoping we forget by Monday.

I am afraid our document dump will not be forgotten and #'s will cause stampede Monday AM - if released today. Just a hunch.

Speaking of Schwab -
Charles Schwab Investment Management Inc reports 5.43% increase in ownership of SRNE / Sorrento Therapeutics Inc

2022-02-11 - Charles Schwab Investment Management Inc has filed a 13F-HR form disclosing ownership of 2,143,094 shares of Sorrento Therapeutics Inc (US:SRNE) with total holdings valued at $9,966,000 USD as of 2021-12-31. Charles Schwab Investment Management Inc had filed a previous 13F-HR on 2021-11-16 disclosing 2,032,750 shares of Sorrento Therapeutics Inc at a value of $15,510,000 USD. This represents a change in shares of 5.43 percent and a change in value of -35.74 percent during the quarter.

Other investors with positions similar to Charles Schwab Investment Management Inc include Northern Trust Corp , Goldman Sachs Group Inc , Geode Capital Management, Llc , Jane Street Group, Llc , Cormorant Asset Management, LP , and BlackRock Fund Advisors .